Paloma Partners Management CO Alnylam Pharmaceuticals, Inc. Put Options Transaction History

Paloma Partners Management CO

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	BUY	$143.31 - $247.0 $14,331 - $24,700	100 New	100 $24,000
Q3 2023 Nov 14, 2023	BUY	$170.77 - $211.65 $341,540 - $423,300	2,000 New	2,000 $354,000
Q1 2023 May 15, 2023	BUY	$182.66 - $235.53 $219,192 - $282,636	1,200 New	1,200 $240,000
Q4 2018 Feb 14, 2019	SELL	$62.67 - $88.33 $175,476 - $247,324	-2,800 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$87.52 - $122.67 $2.16 Million - $3.03 Million	-24,700 Reduced 89.82%	2,800 $245,000
Q2 2018 Aug 14, 2018	BUY	$88.31 - $107.8 $2.43 Million - $2.96 Million	27,500 New	27,500 $2.71 Million

644

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $31.2B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

Stay updated on Paloma Partners Management CO with notifications on news.